| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5927846 | American Heart Journal | 2016 | 31 Pages |
Abstract
X-TRA is the first prospective, multicenter study examining LA/LAA thrombus resolution with a non-VKA oral anticoagulant in VKA-naïve patients or in patients with suboptimal VKA therapy. Rivaroxaban could be a potential option for the treatment of LA/LAA thrombi.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gregory Y.H. MD, Christoph MD, Francisco MD, Riccardo MD, Isabelle Ling MD, Bodo MSc, Martin MD, Ariel MD, X-TRA study and CLOT-AF registry investigators X-TRA study and CLOT-AF registry investigators,